StreetInsider.com News Articles

Form 8-K MiniMed Group, Inc. For: Jun 03

Wed, 03 Jun 2026 06:51:00 -0400

si-local-file:///var/storage/secattach/20260603/26595107.html

MiniMed partners with Abbott for dual glucose-ketone sensors

Wed, 03 Jun 2026 06:49:14 -0400

MiniMed (NASDAQ: MMED) announced an expanded agreement with Abbott to commercialize dual glucose-ketone sensors that will integrate with MiniMed's smart dosing systems. The sensors are designed to monitor both glucose and ketone levels continuously to help prevent diabetic ketoacidosis, a life-threatening complication.

The new sensors will be the same size as Abbott's existing Instinct sensor and will work with MiniMed's automated insulin delivery and Smart MDI systems. The partnership builds on the companies' existing collaboration for the Instinct sensor.

"By integrating dual glucose-ketone monitoring sensors with our MiniMed smart dosing systems, we're adding an additional layer of intelligence and protection," said Que

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Wed, 03 Jun 2026 06:47:00 -0400

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes management

NORTHRIDGE, Calif., June 3, 2026 /PRNewswire/ -- MiniMed (NASDAQ: MMED), a global leader in diabetes technology, today announced an expanded agreement with Abbott to collaborate on commercializing dual glucose-ketone sensors designed to integrate exclusively with MiniMed smart dosing systems.

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Wed, 03 Jun 2026 06:47:00 -0400

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes management

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Wed, 03 Jun 2026 06:47:00 -0400

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes management

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Wed, 03 Jun 2026 06:47:00 -0400

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes management

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Wed, 03 Jun 2026 06:47:00 -0400

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes management

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Wed, 03 Jun 2026 06:47:00 -0400

Agreement builds on the companies' ongoing partnership to expand choice and simplify diabetes management

MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook

Wed, 03 Jun 2026 06:46:00 -0400

Continued momentum in Q4, with net sales of $837 million growing 16% as reported and 9% organic year-over-year
Record annual net sales performance surpasses $3B for first time, growing 14% as reported and 8% organic
Advanced global pipeline ahead of schedule with FDA clearance for MiniMed Flex™, CE Mark for Instinct, and global launch of MiniMed Go™ Smart MDI

NORTHRIDGE, Calif., June 3, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today reported financial results for its fourth quarter and full fiscal year ended April 24, 2026.

MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook

Wed, 03 Jun 2026 06:46:00 -0400

Continued momentum in Q4, with net sales of $837 million growing 16% as reported and 9% organic year-over-year
Record annual net sales performance surpasses $3B for first time, growing 14% as reported and 8% organic
Advanced global pipeline ahead of schedule with FDA clearance for MiniMed Flex™, CE Mark for Instinct, and global launch of MiniMed Go™ Smart MDI

MiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessions

Wed, 27 May 2026 09:07:00 -0400